Phenserine - Next Generation AChE Inhibitor for Alzheimer's Disease (AD)
Key Data:
Drug (Brand / Generic)
Phenserine
Company / Licensee
Axonyx
Therapy Class
AChE inhibitor
Product Description
Dual-acting AChE inhibitor and anti-amyloid agent
Current Indication
Alzheimer's disease
Market Sector
CNS
Development Status
Phase III failed, now testing follow-on compounds
